Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Decci who wrote (9099)	4/30/1998 10:26:00 AM
From: Scott H. Davis	Respond to of 14328

Decci, I sincerely do appreciate the eforts of TRIBY management to grow the company, and 50% is a great growth rate. The problem is in the US, a lot of investors do take analyst estimates very seriously. It's a game. A lot of the S&P biggies have been giving earnings warnings ahead of announcements, analysts lower estimates, price takes a brief, small hit, then when the #s come out, the company comes in 1 or 2 cents above the downward surprise, and now the has a small EPS upward surprise, people muy more, since they beat estimates once again. Upward & downward surprises take on a lot more significance as the % of the surprise increases. It may not be right, but it's a US securities market reality. If any TRIBY management is reading, would you please consider talking to the analyst (with DLJ I believe). A downward revision with a more realistic assessment now, would be a LOT better than qtr after qtr downward surprises. Scott